165 related articles for article (PubMed ID: 28326039)
1. Estrone Sulfate Transport and Steroid Sulfatase Activity in Colorectal Cancer: Implications for Hormone Replacement Therapy.
Gilligan LC; Gondal A; Tang V; Hussain MT; Arvaniti A; Hewitt AM; Foster PA
Front Pharmacol; 2017; 8():103. PubMed ID: 28326039
[TBL] [Abstract][Full Text] [Related]
2. Estrogen Activation by Steroid Sulfatase Increases Colorectal Cancer Proliferation via GPER.
Gilligan LC; Rahman HP; Hewitt AM; Sitch AJ; Gondal A; Arvaniti A; Taylor AE; Read ML; Morton DG; Foster PA
J Clin Endocrinol Metab; 2017 Dec; 102(12):4435-4447. PubMed ID: 28945888
[TBL] [Abstract][Full Text] [Related]
3. Evidence of estrone-sulfate uptake modification in young and middle-aged rat prostate.
Giton F; Sirab N; Franck G; Gervais M; Schmidlin F; Ali T; Allory Y; de la Taille A; Vacherot F; Loric S; Fiet J
J Steroid Biochem Mol Biol; 2015 Aug; 152():89-100. PubMed ID: 25958048
[TBL] [Abstract][Full Text] [Related]
4. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
[TBL] [Abstract][Full Text] [Related]
5. Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells.
Dias NJ; Selcer KW
Steroids; 2014 Oct; 88():77-82. PubMed ID: 25042472
[TBL] [Abstract][Full Text] [Related]
6. Steroid sulfatase in the mouse NIH-3T3 fibroblast cell line: Characterization, and downregulation by glucocorticoids.
Selcer K; Balasubramonian B; Miller D; Kerr J; DiFrancesco M; Ojha S; Urbano R
Steroids; 2021 Oct; 174():108890. PubMed ID: 34280393
[TBL] [Abstract][Full Text] [Related]
7. GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions.
Bustos V; Nolan ÁM; Nijhuis A; Harvey H; Parker A; Poulsom R; McBryan J; Thomas W; Silver A; Harvey BJ
Oncotarget; 2017 Oct; 8(48):84258-84275. PubMed ID: 29137421
[TBL] [Abstract][Full Text] [Related]
8. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
Ishida H; Nakata T; Suzuki M; Shiotsu Y; Tanaka H; Sato N; Terasaki Y; Takebayashi M; Anazawa H; Murakata C; Li PK; Kuwabara T; Akinaga S
Breast Cancer Res Treat; 2007 Dec; 106(2):215-27. PubMed ID: 17268815
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
Stute P; Götte M; Kiesel L
Breast Cancer Res Treat; 2008 Apr; 108(3):363-74. PubMed ID: 17546497
[TBL] [Abstract][Full Text] [Related]
10. Organic anion transporter 1B1: an important factor in hepatic thyroid hormone and estrogen transport and metabolism.
van der Deure WM; Friesema EC; de Jong FJ; de Rijke YB; de Jong FH; Uitterlinden AG; Breteler MM; Peeters RP; Visser TJ
Endocrinology; 2008 Sep; 149(9):4695-701. PubMed ID: 18499754
[TBL] [Abstract][Full Text] [Related]
11. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
12. Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6).
Karakus E; Zahner D; Grosser G; Leidolf R; Gundogdu C; Sánchez-Guijo A; Wudy SA; Geyer J
Front Pharmacol; 2018; 9():941. PubMed ID: 30186172
[TBL] [Abstract][Full Text] [Related]
13. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells.
MacIndoe JH
Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800
[TBL] [Abstract][Full Text] [Related]
14. New insights into the carrier-mediated transport of estrone-3-sulfate in the Caco-2 cell model.
Grandvuinet AS; Gustavsson L; Steffansen B
Mol Pharm; 2013 Sep; 10(9):3285-95. PubMed ID: 23834246
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo.
Ishida H; Nakata T; Sato N; Li PK; Kuwabara T; Akinaga S
Breast Cancer Res Treat; 2007 Aug; 104(2):211-9. PubMed ID: 17061037
[TBL] [Abstract][Full Text] [Related]
16. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.
Rasmussen LM; Zaveri NT; Stenvang J; Peters RH; Lykkesfeldt AE
Breast Cancer Res Treat; 2007 Dec; 106(2):191-203. PubMed ID: 17268816
[TBL] [Abstract][Full Text] [Related]
17. Estrone sulfate and dehydroepiandrosterone sulfate: Transactivation of the estrogen and androgen receptor.
Bjerregaard-Olesen C; Ghisari M; Kjeldsen LS; Wielsøe M; Bonefeld-Jørgensen EC
Steroids; 2016 Jan; 105():50-8. PubMed ID: 26666359
[TBL] [Abstract][Full Text] [Related]
18. Steroid sulfatase activity and expression in mammary myoepithelial cells.
Tobacman JK; Hinkhouse M; Khalkhali-Ellis Z
J Steroid Biochem Mol Biol; 2002 May; 81(1):65-8. PubMed ID: 12127043
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen regulation of bone growth and endocrine function in the ovariectomized rat: discrimination of responses involving estrogen receptor α/estrogen receptor β, G protein-coupled estrogen receptor, or estrogen-related receptor γ using fulvestrant (ICI 182780).
Fitts JM; Klein RM; Powers CA
J Pharmacol Exp Ther; 2011 Jul; 338(1):246-54. PubMed ID: 21464335
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
